DECR1
2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial
Also known as: DECR, DECR_HUMAN, SDR18C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16698
- Gene
- DECR1
- Ensembl
- ENSG00000104325
- Chromosome
- 8
- Canonical length
- 335 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Enables 2,4-dienoyl-CoA reductase (NADPH) activity; NADPH binding activity; and identical protein binding activity. Involved in fatty acid beta-oxidation. Located in cytosol; mitochondrion; and nucleoplasm. Part of catalytic complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
335 residues, UniProt reviewed canonical sequence.
>Q16698|DECR1
1 MKLPARVFFT LGSRLPCGLA PRRFFSYGTK ILYQNTEALQ SKFFSPLQKA MLPPNSFQGK
61 VAFITGGGTG LGKGMTTLLS SLGAQCVIAS RKMDVLKATA EQISSQTGNK VHAIQCDVRD
121 PDMVQNTVSE LIKVAGHPNI VINNAAGNFI SPTERLSPNA WKTITDIVLN GTAFVTLEIG
181 KQLIKAQKGA AFLSITTIYA ETGSGFVVPS ASAKAGVEAM SKSLAAEWGK YGMRFNVIQP
241 GPIKTKGAFS RLDPTGTFEK EMIGRIPCGR LGTVEELANL AAFLCSDYAS WINGAVIKFD
301 GGEEVLISGE FNDLRKVTKE QWDTIEELIR KTKGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DECR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- liver: 70 nTPM
- heart muscle: 33 nTPM
- tongue: 33 nTPM
- skeletal muscle: 27 nTPM
- kidney: 25 nTPM
- bone marrow: 24 nTPM
Single-cell type
- late primary spermatocytes: 433 nCPM
- parietal cells: 354 nCPM
- neutrophils: 333 nCPM
- hepatocytes: 318 nCPM
- enterocytes: 304 nCPM
- esophageal apical cells: 303 nCPM
Immune cell
- neutrophil: 15 nTPM
- intermediate monocyte: 10 nTPM
- T-reg: 9.7 nTPM
- non-classical monocyte: 9.3 nTPM
- classical monocyte: 9 nTPM
- myeloid DC: 8.8 nTPM
Brain region
- choroid plexus: 56 nTPM
- thalamus: 42 nTPM
- basal ganglia: 40 nTPM
- hypothalamus: 38 nTPM
- midbrain: 38 nTPM
- cerebral cortex: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DECR1.
Disease | AllUniProt
Conditions DECR1 is implicated in, by any mechanism.
- 2,4-dienoyl-CoA reductase deficiency (DECRD) MIM:616034
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DECR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DECR1 as an antibody target. Whether an autoantibody or antibody against DECR1 could matter depends on whether native DECR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DECR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DECR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...